Cargando…
Spasticity and Its Contribution to Hypertonia in Cerebral Palsy
Spasticity is considered an important neural contributor to muscle hypertonia in children with cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum Toxin-A. However, treatment response is highly variable. Part of this variability may be due to the inability...
Autores principales: | Bar-On, Lynn, Molenaers, Guy, Aertbeliën, Erwin, Van Campenhout, Anja, Feys, Hilde, Nuttin, Bart, Desloovere, Kaat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306250/ https://www.ncbi.nlm.nih.gov/pubmed/25649546 http://dx.doi.org/10.1155/2015/317047 |
Ejemplares similares
-
Muscle Activation Patterns When Passively Stretching Spastic Lower Limb Muscles of Children with Cerebral Palsy
por: Bar-On, Lynn, et al.
Publicado: (2014) -
Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
por: Bar-On, Lynn, et al.
Publicado: (2020) -
The Intra- and Inter-Rater Reliability of an Instrumented Spasticity Assessment in Children with Cerebral Palsy
por: Schless, Simon-Henri, et al.
Publicado: (2015) -
The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy
por: Hanssen, Britta, et al.
Publicado: (2021) -
Are spasticity, weakness, selectivity, and passive range of motion related to gait deviations in children with spastic cerebral palsy? A statistical parametric mapping study
por: Papageorgiou, Eirini, et al.
Publicado: (2019)